Literature DB >> 34091597

The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase.

Alexandra Daks1, Alexey Petukhov2,3, Olga Fedorova2, Oleg Shuvalov2, Alena Kizenko2, Elizaveta Tananykina2, Elena Vasileva2, Oleg Semenov2, Andrew Bottrill4, Nickolai Barlev5,6.   

Abstract

The RING-finger protein Pirh2 is a p53 family-specific E3 ubiquitin ligase. Pirh2 also ubiquitinates several other important cellular factors and is involved in carcinogenesis. However, its functional role in other cellular processes is poorly understood. To address this question, we performed a proteomic search for novel interacting partners of Pirh2. Using the GST-pulldown approach combined with LC-MS/MS, we revealed 225 proteins that interacted with Pirh2. We found that, according to the GO description, a large group of Pirh2-associated proteins belonged to the RNA metabolism group. Importantly, one of the identified proteins from that group was an RNA-binding protein ELAVL1 (HuR), which is involved in the regulation of splicing and protein stability of several oncogenic proteins. We demonstrated that Pirh2 ubiquitinated the HuR protein facilitating its proteasome-mediated degradation in cells. Importantly, the Pirh2-mediated degradation of HuR occurred in response to heat shock, thereby affecting the survival rate of HeLa cells under elevated temperature. Functionally, Pirh2-mediated degradation of HuR augmented the level of c-Myc expression, whose RNA level is otherwise attenuated by HuR. Taken together, our data indicate that HuR is a new target of Pirh2 and this functional interaction contributes to the heat-shock response of cancer cells affecting their survival.

Entities:  

Year:  2021        PMID: 34091597     DOI: 10.1038/s41419-021-03871-w

Source DB:  PubMed          Journal:  Cell Death Dis            Impact factor:   8.469


  57 in total

1.  Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

Authors:  Roger P Leng; Yunping Lin; Weili Ma; Hong Wu; Benedicte Lemmers; Stephen Chung; John M Parant; Guillermina Lozano; Razqallah Hakem; Samuel Benchimol
Journal:  Cell       Date:  2003-03-21       Impact factor: 41.582

2.  Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination.

Authors:  Hong Wu; Rami Abou Zeinab; Elsa R Flores; Roger P Leng
Journal:  Mol Cancer Res       Date:  2011-10-12       Impact factor: 5.852

3.  Arsenic suppresses cell survival via Pirh2-mediated proteasomal degradation of ΔNp63 protein.

Authors:  Wensheng Yan; Xiufang Chen; Yanhong Zhang; Jin Zhang; Yong-Sam Jung; Xinbin Chen
Journal:  J Biol Chem       Date:  2012-12-27       Impact factor: 5.157

4.  The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

Review 5.  Lysine methylation goes global.

Authors:  Anna Morgunkova; Nick A Barlev
Journal:  Cell Cycle       Date:  2006-06-15       Impact factor: 4.534

6.  Cloning and characterization of an androgen receptor N-terminal-interacting protein with ubiquitin-protein ligase activity.

Authors:  L K Beitel; Y A Elhaji; R Lumbroso; S S Wing; V Panet-Raymond; B Gottlieb; L Pinsky; M A Trifiro
Journal:  J Mol Endocrinol       Date:  2002-08       Impact factor: 5.098

7.  Molecular basis of Pirh2-mediated p53 ubiquitylation.

Authors:  Yi Sheng; Rob C Laister; Alexander Lemak; Bin Wu; Elizabeth Tai; Shili Duan; Jonathan Lukin; Maria Sunnerhagen; Sampath Srisailam; Murthy Karra; Sam Benchimol; Cheryl H Arrowsmith
Journal:  Nat Struct Mol Biol       Date:  2008-11-30       Impact factor: 15.369

8.  Pirh2 promotes ubiquitin-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1.

Authors:  Takayuki Hattori; Tomoyasu Isobe; Kenji Abe; Hirotoshi Kikuchi; Kyoko Kitagawa; Toshiaki Oda; Chiharu Uchida; Masatoshi Kitagawa
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

9.  Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer.

Authors:  Ian R Logan; Luke Gaughan; Stuart R C McCracken; Vasileia Sapountzi; Hing Y Leung; Craig N Robson
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

10.  Pirh2 E3 ubiquitin ligase modulates keratinocyte differentiation through p63.

Authors:  Yong-Sam Jung; Yingjuan Qian; Wensheng Yan; Xinbin Chen
Journal:  J Invest Dermatol       Date:  2012-12-13       Impact factor: 8.551

View more
  5 in total

Review 1.  The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.

Authors:  Abhishek Guha; Saboora Waris; Louis B Nabors; Natalia Filippova; Myriam Gorospe; Thaddaeus Kwan; Peter H King
Journal:  Adv Drug Deliv Rev       Date:  2021-12-16       Impact factor: 15.470

Review 2.  The Role of E3 Ligase Pirh2 in Disease.

Authors:  Alexandra Daks; Olga Fedorova; Sergey Parfenyev; Ivan Nevzorov; Oleg Shuvalov; Nickolai A Barlev
Journal:  Cells       Date:  2022-04-30       Impact factor: 7.666

Review 3.  Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition.

Authors:  Oleg Semenov; Alexandra Daks; Olga Fedorova; Oleg Shuvalov; Nickolai A Barlev
Journal:  Front Mol Biosci       Date:  2022-06-23

Review 4.  The RNA-binding protein HuR in human cancer: A friend or foe?

Authors:  Xiaoqing Wu; Liang Xu
Journal:  Adv Drug Deliv Rev       Date:  2022-03-03       Impact factor: 17.873

5.  Priming, Triggering, Adaptation and Senescence (PTAS): A Hypothesis for a Common Damage Mechanism of Steatohepatitis.

Authors:  Peter M Abuja; Kurt Zatloukal; Helmut Denk
Journal:  Int J Mol Sci       Date:  2021-11-21       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.